Xinglu Zhou Selected Research

Xinglu Zhou Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 01/2009
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2013 - 12/2010
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2014
3	Stomach Neoplasms (Stomach Cancer) 07/2015 - 01/2014
3	Leukemia 02/2013 - 12/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
2	Breast Neoplasms (Breast Cancer) 10/2021 - 09/2017
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 07/2015
2	Acute Promyelocytic Leukemia 02/2013 - 12/2010
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Cognitive Dysfunction 01/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019
1	Carcinogenesis 07/2015
1	Lymphatic Metastasis 01/2014
1	Multiple Myeloma 02/2013
1	Weight Loss (Weight Reduction) 02/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2013
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2011
1	Hypersensitivity (Allergy) 01/2009

Drug/Important Bio-Agent (IBA)

3	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2013 - 12/2010
3	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2013 - 12/2010
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2011
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2009
2	Biological ProductsIBA 07/2015 - 01/2011
2	Bortezomib (Velcade)FDA Link 02/2013 - 01/2013
2	Proteasome InhibitorsIBA 02/2013 - 01/2011
2	RetinoidsIBA 02/2013 - 01/2011
2	UbiquitinIBA 01/2011 - 12/2010
1	Fetal Proteins (Fetoprotein)IBA 01/2022
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	IonsIBA 11/2021
1	Disulfiram (Antabuse)FDA Link 11/2021
1	manganese dioxideIBA 11/2021
1	AntioxidantsIBA 11/2021
1	ProdrugsIBA 11/2021
1	Anticarcinogenic AgentsIBA 11/2021
1	Glucose OxidaseIBA 11/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 11/2021
1	Photosensitizing Agents (Photosensitizers)IBA 10/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2021
1	MetalsIBA 10/2021
1	MicellesIBA 03/2021
1	Oxygen (Dioxygen)IBA 03/2021
1	MelatoninIBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2019
1	Growth Factor ReceptorsIBA 01/2019
1	ibrutinibIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 09/2017
1	Long Noncoding RNAIBA 09/2017
1	Micrococcal NucleaseIBA 07/2015
1	MicroRNAs (MicroRNA)IBA 07/2015
1	Cantharidin (Cantharides)IBA 12/2014
1	VimentinIBA 01/2014
1	Cadherins (E-Cadherin)IBA 01/2014
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 02/2013
1	Mitogen-Activated Protein KinasesIBA 01/2013
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2013
1	STAT1 Transcription FactorIBA 01/2013
1	Differentiation AntigensIBA 01/2013
1	Dasatinib (BMS 354825)FDA Link 01/2013
1	Imatinib Mesylate (Gleevec)FDA Link 01/2013
1	Ubiquitinated ProteinsIBA 12/2010
1	Messenger RNA (mRNA)IBA 12/2010
1	Chalcone (Benzalacetophenone)IBA 08/2010
1	isobavachalconeIBA 08/2010
1	Protein Kinase CIBA 07/2009
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2009
1	Subfamily B ATP Binding Cassette TransporterIBA 01/2009

Therapy/Procedure

8	Therapeutics 11/2021 - 07/2009
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022
1	Nanospheres 11/2021
1	Drug Therapy (Chemotherapy) 11/2021
1	Photochemotherapy (Photodynamic Therapy) 10/2021